Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Airway Responsiveness in AECOPD Mechanical Ventilation
NCT02592122Unknown
- Start
- Oct 2013
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of salbutamol in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoints: Airway resistance at 1 day and Intrinsic Positive End-Expiratory Pressure at 1 day. Status: unknown.
02
Drugs
salbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02592122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02592122.